Boxer Capital’s Tectonic Therapeutic TECX Stock Holding History

Boxer Capital’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,000	Closed	-$8.47M	–	59
2019 Q3	$8.47M	Buy	+50,000	New	+$11.3M	0.61%	33

Other funds holding TECX

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital's TECX Position: Q4 2019 in Review

Boxer Capital sold out of Tectonic Therapeutic (TECX) in Q4 2019, closing a stake of 50,000 shares — an estimated $8.47M sold.

Boxer Capital first reported a position in TECX in Q3 2019 and held it in 1 quarter. The position peaked at $8.47M in Q3 2019. 89 funds tracked by Wall St. Rank hold TECX as of Q4 2019.

Boxer Capital reported no remaining Tectonic Therapeutic position as of Q4 2019 after selling out during the quarter.
Boxer Capital sold 50,000 Tectonic Therapeutic shares in Q4 2019, an estimated $8.47M.
Boxer Capital first reported a position in Tectonic Therapeutic in Q3 2019 and held it in 1 quarter.
Boxer Capital's Tectonic Therapeutic position peaked at $8.47M in Q3 2019.
89 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2019.

Based on Boxer Capital's 13F filing for Q4 2019, filed 14 Feb 2020.